Pulmonary Delivery of Resveratrol-Loaded Nanocomposite Microparticles to Treat Lung Cancer
January 2020
Studysummary This study found that resveratrol-loaded polymeric nanoparticles show promise as a pulmonary drug delivery system for lung cancer, reducing resveratrol's IC50 significantly in Calu 3 cells.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on researchonline.ljmu.ac.uk →